Clinical trial
A Prospective, Non-interventional, Observational Study To Describe the Effectiveness of Trandolapril (Mavik®) in the Management of Patients Requiring Angiotensin Converting Enzyme Inhibitor Treatment (In-MAU-tion)
NCT01078584 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Non-interventional, Observational Study To Describe the Effectiveness of Trandolapril (Mavik®) in the Management of Patients Requiring Angiotensin Converting Enzyme Inhibitor Treatment (In-MAU-tion)
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- September 30, 2011
- Enrollment
- 7,993 (actual)
- Sites
- 568
Conditions
As the registry lists them; a condition with its own page is linked.